Pfizer Just Canned One of Its Ozempic Killers. What's Next?

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Jul 03, 2023 at 10:42: AM
via
  • Pfizer discontinued one of its candidates to treat diabetes and obesity.
  • Even if it hadn't been discontinued, competing medicines would likely win out.
  • Don't hold your breath for the company's other candidate accomplishing much.

article source
 

<



Similar threads

cafead
ESMO: Pfizer sees weight gain in cancer patients, aims to enter phase 3 in 2025
Replies
0
Views
11
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
AstraZeneca steps out from Daiichi&#039;s shadow, posting data on in-house rivals to AbbVie and Pfizer ADCs
Replies
0
Views
12
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Pfizer pushing BRAF lung cancer mutation testing to grow market for Braftovi
Replies
0
Views
7
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Valneva and Pfizer report positive data from trial of Lyme disease vaccine booster
Replies
0
Views
17
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Vaxcyte&#039;s &#039;stunning&#039; 31-valent pneumococcal vaccine win against Pfizer&#039;s Prevnar 20 has analysts thinking big
Replies
0
Views
20
Pharma/Biotech Companies - In the News
cafead
cafead
Top Bottom
Back
Quote